Cargando…

Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes

BACKGROUND: Modern drugs have made great contributions to better quality of life, less disabling symptoms, decreased demands of health care and a better prognosis. Despite this, one can nowadays notice an increasing proportion of negative side effects and adverse drug reactions due to extensive phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsson, Inger Nordin, Engfeldt, Peter
Formato: Texto
Lenguaje:English
Publicado: Igitur, Utrecht Publishing & Archiving 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430294/
_version_ 1782156390860587008
author Olsson, Inger Nordin
Engfeldt, Peter
author_facet Olsson, Inger Nordin
Engfeldt, Peter
author_sort Olsson, Inger Nordin
collection PubMed
description BACKGROUND: Modern drugs have made great contributions to better quality of life, less disabling symptoms, decreased demands of health care and a better prognosis. Despite this, one can nowadays notice an increasing proportion of negative side effects and adverse drug reactions due to extensive pharmacological treatment. STUDY OBJECTIVES: To examine if patient-focused drug surveillances were associated with a higher quality of drug treatment at nursing homes? METHODS: Physicians were told to systematically focus on the patient's basic health status as a fundamental starting point for further continuous medication, with the aim to obtain a rational drug usage. SETTING: An intervention study in nursing homes in Sweden. OUTCOMES: Mortality, health care consumption and number of drugs. Health status and evaluation of drug therapy. RESULTS: No significant difference in mortality rate. Extensive health care consumption in both groups. Significant differences of examinations like weight, blood pressure and renal function. Monitoring and evaluation of medications showed significant differences favouring the intervention group. Due to existing polypharmacy there was a significant reduction of number of drugs in the intervention group vs. a significant increase in the control group. CONCLUSIONS: The intervention seemed to have achieved significant positive results in ‘quality of drug treatment’, although it has shown immense lacks of monitoring the health status of frail elderly.
format Text
id pubmed-2430294
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Igitur, Utrecht Publishing & Archiving
record_format MEDLINE/PubMed
spelling pubmed-24302942008-06-18 Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes Olsson, Inger Nordin Engfeldt, Peter Int J Integr Care Conference Abstract BACKGROUND: Modern drugs have made great contributions to better quality of life, less disabling symptoms, decreased demands of health care and a better prognosis. Despite this, one can nowadays notice an increasing proportion of negative side effects and adverse drug reactions due to extensive pharmacological treatment. STUDY OBJECTIVES: To examine if patient-focused drug surveillances were associated with a higher quality of drug treatment at nursing homes? METHODS: Physicians were told to systematically focus on the patient's basic health status as a fundamental starting point for further continuous medication, with the aim to obtain a rational drug usage. SETTING: An intervention study in nursing homes in Sweden. OUTCOMES: Mortality, health care consumption and number of drugs. Health status and evaluation of drug therapy. RESULTS: No significant difference in mortality rate. Extensive health care consumption in both groups. Significant differences of examinations like weight, blood pressure and renal function. Monitoring and evaluation of medications showed significant differences favouring the intervention group. Due to existing polypharmacy there was a significant reduction of number of drugs in the intervention group vs. a significant increase in the control group. CONCLUSIONS: The intervention seemed to have achieved significant positive results in ‘quality of drug treatment’, although it has shown immense lacks of monitoring the health status of frail elderly. Igitur, Utrecht Publishing & Archiving 2008-06-04 /pmc/articles/PMC2430294/ Text en Copyright 2008, International Journal of Integrated Care (IJIC)
spellingShingle Conference Abstract
Olsson, Inger Nordin
Engfeldt, Peter
Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title_full Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title_fullStr Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title_full_unstemmed Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title_short Patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
title_sort patient focused drug surveillance on elderly patients with chronic diseases in nursing homes
topic Conference Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430294/
work_keys_str_mv AT olssoningernordin patientfocuseddrugsurveillanceonelderlypatientswithchronicdiseasesinnursinghomes
AT engfeldtpeter patientfocuseddrugsurveillanceonelderlypatientswithchronicdiseasesinnursinghomes